Atlas Trials

Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy

Clinical trial NCT04181203 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04181203
Sponsor
UNICANCER
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2020-01-09
Primary completion
2028-09-28
Enrollment
490

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.